Wang J - Search Results

1

PC-1/PrLZ contributes to malignant progression in prostate cancer.

Zhang H, Wang J, Pang B, Liang RX, Li S, Huang PT, Wang R, Chung LW, Zhau HE, Huang C, Zhou JG. Zhang H, et al. Among authors: wang j, wang r. Cancer Res. 2007 Sep 15;67(18):8906-13. doi: 10.1158/0008-5472.CAN-06-4214. Cancer Res. 2007. PMID: 17875733

2

Identification and characterization of the novel human prostate cancer-specific PC-1 gene promoter.

Wang J, Zhang H, Liang RX, Pang B, Shi QG, Huang PT, Huang CF, Zhou JG. Wang J, et al. Biochem Biophys Res Commun. 2007 May 25;357(1):8-13. doi: 10.1016/j.bbrc.2007.02.153. Epub 2007 Mar 7. Biochem Biophys Res Commun. 2007. PMID: 17418805

3

Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.

Pang B, Zhang H, Wang J, Chen WZ, Li SH, Shi QG, Liang RX, Xie BX, Wu RQ, Qian XL, Yu L, Li QM, Huang CF, Zhou JG. Pang B, et al. Among authors: wang j. Prostate. 2009 Aug 1;69(11):1176-87. doi: 10.1002/pros.20969. Prostate. 2009. PMID: 19415690

4

Analysis of differentially expressed genes in LNCaP prostate cancer progression model.

Xie BX, Zhang H, Wang J, Pang B, Wu RQ, Qian XL, Yu L, Li SH, Shi QG, Huang CF, Zhou JG. Xie BX, et al. Among authors: wang j. J Androl. 2011 Mar-Apr;32(2):170-82. doi: 10.2164/jandrol.109.008748. Epub 2010 Sep 23. J Androl. 2011. PMID: 20864652

5

The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP.

Xie BX, Zhang H, Yu L, Wang J, Pang B, Wu RQ, Qian XL, Li SH, Shi QG, Wang LL, Zhou JG. Xie BX, et al. Among authors: wang ll, wang j. Asian J Androl. 2010 May;12(3):405-14. doi: 10.1038/aja.2009.91. Epub 2010 Feb 2. Asian J Androl. 2010. PMID: 20118949 Free PMC article.

6

Spondin-2 (SPON2), a more prostate-cancer-specific diagnostic biomarker.

Qian X, Li C, Pang B, Xue M, Wang J, Zhou J. Qian X, et al. Among authors: wang j. PLoS One. 2012;7(5):e37225. doi: 10.1371/journal.pone.0037225. Epub 2012 May 15. PLoS One. 2012. PMID: 22615945 Free PMC article.

7

SGEF is overexpressed in prostate cancer and contributes to prostate cancer progression.

Wang H, Wu R, Yu L, Wu F, Li S, Zhao Y, Li H, Luo G, Wang J, Zhou J. Wang H, et al. Among authors: wang j. Oncol Rep. 2012 Oct;28(4):1468-74. doi: 10.3892/or.2012.1917. Epub 2012 Jul 19. Oncol Rep. 2012. PMID: 22824926

8

EphA3, induced by PC-1/PrLZ, contributes to the malignant progression of prostate cancer.

Wu R, Wang H, Wang J, Wang P, Huang F, Xie B, Zhao Y, Li S, Zhou J. Wu R, et al. Among authors: wang h, wang j, wang p. Oncol Rep. 2014 Dec;32(6):2657-65. doi: 10.3892/or.2014.3482. Epub 2014 Sep 16. Oncol Rep. 2014. PMID: 25231727

9

Cryptotanshinone inhibits breast cancer cell growth by suppressing estrogen receptor signaling.

Li S, Wang H, Hong L, Liu W, Huang F, Wang J, Wang P, Zhang X, Zhou J. Li S, et al. Among authors: wang h, wang j, wang p. Cancer Biol Ther. 2015;16(1):176-84. doi: 10.4161/15384047.2014.962960. Cancer Biol Ther. 2015. PMID: 25482936 Free PMC article.

10

PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability.

Yu L, Shang ZF, Wang J, Wang H, Huang F, Zhang Z, Wang Y, Zhou J, Li S. Yu L, et al. Among authors: wang h, wang j, wang y. Oncotarget. 2015 Aug 21;6(24):20356-69. doi: 10.18632/oncotarget.3931. Oncotarget. 2015. PMID: 26011939 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215,586 results

Search Page

Filters